Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to 0.09.

  • Fennec Pharmaceuticals' Equity Ratio fell 390.4% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year decrease of 390.4%. This contributed to the annual value of 0.13 for FY2024, which is 6980.15% up from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported Equity Ratio of 0.09 as of Q3 2025, which was down 390.4% from 0.17 recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Equity Ratio registered a high of 0.9 during Q1 2021, and its lowest value of 0.5 during Q2 2023.
  • Moreover, its 5-year median value for Equity Ratio was 0.05 (2024), whereas its average is 0.12.
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 42060.35% in 2023, then plummeted by 67404.9% in 2025.
  • Quarter analysis of 5 years shows Fennec Pharmaceuticals' Equity Ratio stood at 0.73 in 2021, then crashed by 113.05% to 0.1 in 2022, then tumbled by 353.66% to 0.43 in 2023, then surged by 69.8% to 0.13 in 2024, then skyrocketed by 30.2% to 0.09 in 2025.
  • Its Equity Ratio was 0.09 in Q3 2025, compared to 0.17 in Q2 2025 and 0.13 in Q1 2025.